BioNexus Gene Lab Corp. Operating Lease, Liability, Noncurrent
BioNexus Gene Lab Corp. (BGLC) had Operating Lease, Liability, Noncurrent of $89.35 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Noncurrent $89.35K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $103.80K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $116.90K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $126.94K.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $89.35K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $103.80K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $116.90K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $126.94K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $141.35K 10-Q · filed 2025-08-18 | |
| 2025-03-31 | $147.94K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $159.74K 10-K · filed 2026-04-14 | |
| 2024-09-30 | $178.37K 10-Q · filed 2024-11-15 | |
| 2024-06-30 | $182.70K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $88.85K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $98.76K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $104.87K 10-Q/A · filed 2024-03-26 | |
| 2023-06-30 | $29.66K 10-Q · filed 2023-08-16 | |
| 2023-03-31 | $35.68K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $40.21K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $14.12K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $17.69K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $21.49K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $24.64K 10-K · filed 2023-03-31 | $12.80K 10-K · filed 2022-04-06 |
| 2021-09-30 | $28.68K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $33.69K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $39.91K 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $42.38K 10-K · filed 2022-04-06 | |
| 2020-09-30 | $3.97K 10-Q/A · filed 2020-11-09 | |
| 2020-06-30 | $5.74K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $8.66K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $12.21K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |